5 completed, 2 active not recruiting, 1 recruiting, 1 unknown. 9 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Completed 5, Active not recruiting 2, Recruiting 1, Unknown 1 |
| Phase 3 | 2 | Completed 1, Recruiting 1 |
Follow Clavulanic Acid: new trials by email Literature Review of Clavulanic Acid trials Research Report on Clavulanic Acid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clavulanic Acid for the Treatment of Cocaine Use Disorder Clavulanic Acid Only Product, Placebo - Cocaine Dependence | Phase 2 | Active not recruiting | Temple University | 65 | 2023-05-03 | 2024-05-02 |
| Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension trimethoprim-sulfamethoxazole (co-trimoxazole), amoxycillin/clavulanic acid and ciprofloxacin, Immunoglobulins - Haematological Malignancy, Hypogammaglobulinemia | Phase 2 / Phase 3 | Recruiting | Monash University | 300 | 2022-11-30 | 2024-04-19 |
| Beta-Lactam Containing Regimen for the Shortening of Buruli Ulcer Disease Therapy Standard [RC8]: rifampicin plus clarithromycin (RC) therapy for 8 weeks., Investigational [RCA4]: standard (RC) plus amoxicillin/clavulanate (A) for 4 weeks. - Buruli Ulcer | Phase 2 | Unknown | Fundacion Agencia Aragonesa para la Investigacion y Desarrollo (ARAID) | 140 | 2021-12-01 | 2024-05-16 |
| An fMRI Study of the Effects of Clavulanic Acid on Drug Addiction Clavulanic Acid, Placebo oral capsule - Tobacco Use Disorder | Phase 2 | Active not recruiting | University of Missouri-Columbia | 30 | 2019-03-26 | 2026-10-07 |
| Early Bactericidal Activity of Rifampin + Meropenem + Amoxicillin/Clavulanate in Adults With Pulmonary TB Rifampin, MEROPENEM 2 grams TID, MEROPENEM 1 gram TID - Tuberculosis, Pulmonary | Phase 2 | Completed | Johns Hopkins University | 112 | 2017-08-23 | 2023-07-19 |
| Technology That Permits Focal Dose of Antibiotics to be Delivered to Lower Limb(s) of Diabetic Patients Percutaneous Isolated Limb Perfusion (PILP) delivery, Timentin - Diabetes, Infection | Phase 2 | Completed | Osprey Medical, Inc | 15 | 2013-10-01 | 2016-09-30 |
| A Study Of Intravenous Sulopenem And Oral PF-03709270 In Community Acquired Pneumonia That Requires Hospitalization sulopenem and PF-03709270, Sulopenem and PF-03709270, Ceftriaxone and amoxicillin/clavulanate - Pneumonia, Bacterial | Phase 2 | Completed | Pfizer | 35 | 2009-01-01 | 2016-03-10 |
| Use of Probiotic Lactobacilli for the Treatment of Lactational Mastitis Lactobacillus salivarius HN6, Lactobacillus reuteri CR20, Lactobacillus fermentum LC40 - Mastitis | Phase 2 / Phase 3 | Completed | Universidad Complutense de Madrid | 300 | 2008-07-01 | 2009-05-25 |
| An Investigational Agent for the Treatment of Complicated Intra-Abdominal Infections or Acute Pelvic Infections (0826-038) MK0826, ertapenem sodium, Comparator: Ticarcillin/Clavulanate - Infections, Pelvic Infections | Phase 2 | Completed | Merck Sharp & Dohme LLC | 100 | 2002-03-01 | 2017-02-17 |
Infections (3) · Agammaglobulinemia (1) · Breast Feeding (1) · Buruli Ulcer (1) · Cocaine-Related Disorders (1) · Diabetes Mellitus (1) · Hematologic Neoplasms (1) · Intraabdominal Infections (1) · Leukemia (1) · Lymphoma (1) · Mastitis (1) · Neglected Diseases (1) · Neoplasms (1) · Neoplasms, Plasma Cell (1) · Pelvic Infection (1)
Fundacion Agencia Aragonesa para la Investigacion y Desarrollo (ARAID) (1) · Johns Hopkins University (1) · Merck Sharp & Dohme LLC (1) · Monash University (1) · Osprey Medical, Inc (1) · Pfizer (1) · Temple University (1) · Universidad Complutense de Madrid (1) · University of Missouri-Columbia (1)
Australia (3) · United States (3) · Benin (1) · Canada (1) · Poland (1) · South Africa (1) · South Korea (1) · Spain (1)
Brett Froeliger, PhD (1) · Kelly Dooley, MD (1) · Mary Morrison, MD, MS (1) · Paul Wraight, Assoc. Prof. (1) · Prof Erica Wood (1) · Prof Zoe McQuilten (1)
PMID 20455694, PMID 24880136, PMID 26543027, PMID 35258443, PMID 35804454, PMID 38573915, PMID 40455216, PMID 42104494
2008 (1)